Sphera Funds Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELDN
Sphera Funds Management's ELDN Position: Q3 2026 in Review
Sphera Funds Management increased its Eledon Pharmaceuticals (ELDN) stake by 17% in Q3 2026, buying an estimated $675K and bringing the position to 1,392,187 shares worth $3.52M. The position accounts for 0.5% of the portfolio, ranked #69.
Sphera Funds Management first reported a position in ELDN in Q3 2014 and has held it in 13 quarters since. The position peaked at $10.5M in Q4 2024. 155 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.
- Sphera Funds Management held 1,392,187 shares of Eledon Pharmaceuticals worth $3.52M as of Q3 2026.
- Sphera Funds Management bought 201,000 Eledon Pharmaceuticals shares in Q3 2026, an estimated $675K.
- Eledon Pharmaceuticals made up 0.5% of Sphera Funds Management's portfolio in Q3 2026, its #69 holding.
- Sphera Funds Management first reported a position in Eledon Pharmaceuticals in Q3 2014 and has held it in 13 quarters since.
- Sphera Funds Management's Eledon Pharmaceuticals position peaked at $10.5M in Q4 2024.
- 155 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.
Based on Sphera Funds Management's 13F filing for Q3 2026, filed 16 Nov 2026.